Managers / Q4 2021 · view latest →
Spouting Rock Asset Management, LLC
CIK 0001771174 · 925 W. LANCASTER AVENUE, SUITE 250, BRYN MAWR, PA, 19010 · 610-788-2128
Summary
Spouting Rock Asset Management, LLC reported $128M in U.S.-listed holdings across 59 positions for Q4 2021.
Its largest position, 8CW, represents 6.7% of the portfolio.
Compared with Q3 2021, the fund opened 7 new positions and exited 49.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.4% · $106M
- REIT · 14.7% · $19M
- Other · 1.7% · $2M
- ADR · 0.2% · $257,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| RHPRYMAN HOSPITALITY PPTYS INC | NEW | +22.5K | 22.5K | +$2M | $2M |
| SMARGBPSMARTSHEET INC | NEW | +10.2K | 10.2K | +$786,000 | $786,000 |
| IASINTEGRAL AD SCIENCE HLDNG CO | NEW | +10.6K | 10.6K | +$235,000 | $235,000 |
| ATECALPHATEC HLDGS INC | NEW | +20.2K | 20.2K | +$231,000 | $231,000 |
| OLOGBXOLO INC | NEW | +10.5K | 10.5K | +$218,000 | $218,000 |
| HLMNHILLMAN SOLUTIONS CORP | NEW | +19.8K | 19.8K | +$213,000 | $213,000 |
| ATRSEURANTARES PHARMA INC | NEW | +56.3K | 56.3K | +$201,000 | $201,000 |
| AXONAXON ENTERPRISE INC | SOLD OUT | −17.4K | 0 | −$3M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2023 | $273M | 118 | Feb 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $313M | 152 | Nov 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $276M | 157 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $284M | 175 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $135M | 140 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $130M | 142 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $154M | 133 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $120M | 56 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $128M | 59 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $201M | 101 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $326M | 204 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $323M | 207 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $316M | 173 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $209M | 134 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $210M | 134 | Aug 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $392M | 150 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.